following an abbreviated submission:
ciprofloxacin ear drops (Cetraxal®) are accepted for restricted use within NHS Scotland.
Indication under review: treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms.
SMC restriction: when off-label or unlicensed ciprofloxacin formulations would otherwise be used.
Ciprofloxacin eye drops (used off-label) or unlicensed ciprofloxacin ear drops have been in use in NHS Scotland for this indication. Ciprofloxacin ear drops (Cetraxal®) provide a licensed alternative.
Download detailed advice126KB (PDF)
- Medicine name:
- ciprofloxacin hydrochloride (Cetraxal)
- SMC ID:
- Treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms.
- Pharmaceutical company
- Aspire Pharma Ltd
- BNF chapter
- Ear, nose and oropharynx
- Submission type
- Date advice published:
- 09 April 2018